Method for the diagnosis, prognosis and treatment of lung cancer metastasis
US11352673B2 · kind B2 · utility
4Cited by
20References
15Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 21, 2018 |
| Grant date | Jun 7, 2022 |
| Priority date | — |
| Expiry date | May 7, 2039 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2800/52
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a method for the diagnosis or the prognosis of metastasis in lung cancer which comprises determining if the c-MAF gene is amplified in a primary tumor sample. Likewise, the invention also relates to a method for the diagnosis or the prognosis of metastasis in lung cancer, as well as to a method for determining the tendency to develop bone metastasis with respect to metastasis in other organs, which comprise determining the c-MAF gene expression level. Finally, the invention relates to the use of a c-MAF inhibitor as therapeutic target for treating the lung cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.